Pro-Life Spokesperson Objects To FDA Action On Morning-After Pill

Main Category: Women's Health / Gynecology
Also Included In: Fertility;  Sexual Health / STDs
Article Date: 01 Aug 2006 - 0:00 PDT

email icon email to a friend   printer icon printer friendly   write icon opinions  

Current Article Ratings:

Patient / Public:5 stars

5 (1 votes)

Healthcare Prof:1 star

1 (3 votes)


Deirdre McQuade, pro-life spokeswoman for the U.S. Conference of Catholic Bishops, reacted strongly to the Food and Drug Administration (FDA) announcement on July 31 moving toward over-the- counter (OTC) availability of Plan B for women eighteen and older.

"Making this powerful, abortifacient drug available without a doctor's oversight could place women and their newly-conceived children at risk," Ms. McQuade said.

Plan B -- also known as the "morning-after pill" -- is essentially a megadose of prescription hormonal birth-control pills. "Plan B is marketed as a contraceptive but even its proponents admit that it works both before and after conception," Ms. McQuade said.

"Over-the-counter availability would allow these drugs to be used routinely, despite the fact that they are not approved for such use. Studies presented to the FDA confirm that many women do not understand that the pills should not be used routinely," McQuade said. "Many are also unaware of their abortifacient action."

"Women for whom the drug is dangerous would not have the benefit of any clinical advice to alert them to the risks," McQuade said. One physician who supports OTC availability of Plan B concedes that "repeated use of [emergency contraception] wreaks havoc on a woman's cycle" with "resulting menstrual chaos."

"It would also place additional pressure on pharmacists who conscientiously object to dispensing drugs that can kill humans at their earliest stages of development," Ms. McQuade continued.

"As surprising as it may seem to proponents of Plan B, a 2005 study co- authored by a Planned Parenthood doctor in the Journal of the American Medical Association showed that having Plan B on hand did nothing to reduce pregnancy rates compared to those who obtained the drug from a pharmacy," McQuade noted.

Secretariat for Pro-Life Activities of the United States Conference
http://www.usccb.org/prolife

Article adapted by Medical News Today from original press release.
Visit our women's health / gynecology section for the latest news on this subject.
There are no references listed for this article.
Please use one of the following formats to cite this article in your essay, paper or report:

MLA
Christopher Backing. "Pro-Life Spokesperson Objects To FDA Action On Morning-After Pill." Medical News Today. MediLexicon, Intl., 1 Aug. 2006. Web.
16 Feb. 2012. <http://www.medicalnewstoday.com/releases/48400.php>

APA
Christopher Backing. (2006, August 1). "Pro-Life Spokesperson Objects To FDA Action On Morning-After Pill." Medical News Today. Retrieved from
http://www.medicalnewstoday.com/releases/48400.php.

Please note: If no author information is provided, the source is cited instead.


Women's Health / Gynecology

Most Popular Articles



Follow Our Women's Health News On Twitter

Follow Us On Twitter
Get the latest news for this category delivered straight to your Twitter account. Simply visit our Women's Health / Gynecology Twitter account and select the 'follow' option.



View list of all 'What Is...' articles »